Boston Globe: Neumora hopes to bring precision medicine to brain disease treatments
Read More
Archive for Neumora in the News
Boston Business Journal: Psychiatric drug startup launches with $500M, Amgen partnership
Read More
Chemical & Engineering News: Neumora launches with $500 million to develop drugs for brain diseases
Read More
FierceBiotech: Meet Neumora, Arch’s $500M, Amgen-partnered play for the targeted future of neuroscience R&D
Read More
Daily Mail: Amgen to invest $100 million in SoftBank-backed Neumora
Read More